CONMED Corporation (CNMD)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inventory turnover | 1.71 | 1.72 | 1.82 | 1.79 | 1.78 | 1.67 | 1.62 | 1.51 | 1.43 | 1.55 | 1.58 | 1.75 | 1.91 | 1.93 | 2.08 | 2.00 | 2.06 | 2.23 | 2.32 | 2.45 |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Working capital turnover | 3.61 | 3.59 | 3.56 | 3.66 | 4.08 | 4.69 | 4.34 | 3.80 | 3.67 | 2.92 | 2.77 | 3.39 | 3.84 | 3.80 | 4.00 | 3.64 | 3.81 | 3.88 | 3.82 | 4.08 |
The activity ratios of CONMED Corporation provide insights into how efficiently the company manages its assets and liabilities to generate sales.
1. Inventory Turnover: CONMED's inventory turnover has been gradually declining from 2.45 in March 2020 to 1.71 in December 2024, indicating that the company is taking longer to sell its inventory. This may suggest issues with inventory management or potential slow sales.
2. Receivables Turnover: There is no data available for receivables turnover, which signifies that information on how effectively the company collects on its sales is unavailable.
3. Payables Turnover: Similarly, there is no data provided for payables turnover, making it difficult to assess how efficiently the company manages its trade payables.
4. Working Capital Turnover: The working capital turnover ratio fluctuates over the years, ranging from 2.77 in June 2022 to 4.69 in September 2023. A higher turnover indicates efficient utilization of working capital to generate sales, while a lower ratio suggests inefficiencies in the utilization of working capital.
Overall, while the company's working capital turnover reflects some fluctuations, the lack of data for receivables and payables turnover hinders a comprehensive analysis of CONMED Corporation's activity ratios.
Average number of days
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 213.57 | 212.76 | 200.62 | 204.29 | 205.15 | 219.16 | 225.59 | 240.95 | 255.78 | 235.05 | 231.70 | 208.25 | 191.03 | 188.84 | 175.54 | 182.53 | 176.86 | 163.52 | 157.55 | 148.74 |
| Days of sales outstanding (DSO) | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
CONMED Corporation's Days of Inventory on Hand (DOH) increased steadily from 148.74 days as of March 31, 2020, to 213.57 days as of December 31, 2024. This trend indicates that the company is holding its inventory for a longer period, which may tie up valuable resources and lead to higher carrying costs.
However, there is a lack of available data for Days of Sales Outstanding (DSO) and Number of Days of Payables, which limits the ability to assess the efficiency of CONMED's accounts receivable and accounts payable management.
Overall, the increasing trend in Days of Inventory on Hand warrants further investigation into CONMED Corporation's inventory management practices to optimize efficiency and minimize potential risks associated with excess inventory levels.
Long-term
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fixed asset turnover | — | — | — | — | — | 9.70 | 9.75 | 9.52 | 9.04 | 9.40 | 9.34 | 9.40 | 9.28 | 9.06 | 9.08 | 8.06 | 7.74 | 7.79 | 7.69 | 8.32 |
| Total asset turnover | 0.57 | 0.56 | 0.56 | 0.55 | 0.54 | 0.50 | 0.49 | 0.47 | 0.46 | 0.47 | 0.50 | 0.57 | 0.57 | 0.56 | 0.56 | 0.50 | 0.49 | 0.50 | 0.50 | 0.54 |
The fixed asset turnover ratio for CONMED Corporation has shown a positive trend over the years, increasing steadily from 8.32 in March 2020 to 9.52 in March 2023. This indicates that the company is generating more revenue for each dollar invested in fixed assets, reflecting efficient utilization of its fixed assets.
In contrast, the total asset turnover ratio fluctuated over the same period, starting at 0.54 in March 2020, peaking at 0.57 in December 2021, and then slightly declining to 0.56 by September 2024. This suggests that the company's ability to generate sales from its total assets has been mixed but relatively consistent.
Overall, the upward trend in the fixed asset turnover ratio coupled with the somewhat stable total asset turnover ratio indicates that CONMED Corporation has been effectively managing its fixed assets to drive revenue growth, although there may be opportunities to further optimize its total asset utilization.